The HTX TechList — launching August 13 — will help connect the dots in Houston's sprawled and burgeoning innovation ecosystem. Getty Images

With a city as diverse and sprawling as Houston, the local innovation ecosystem could stand to benefit from a platform that connects all the dots virtually. So, that's exactly what Houston Exponential created.

HX — a nonprofit dedicated to promoting innovation in Houston — is launching HTX TechList August 13, and the platform will consist of profiles for startups, investors, startup development organizations, and corporations and will act as both a database as well as a forum for innovators to interact.

"The problem we've been solving for such a long time has been [not having] dependable data that you can rely on," says Serafina Lalany, chief of staff at HX. "We're taking responsibility for the curation for it and the quality assurance of it."

The fact of the matter is there's no one source for data and information on startups in Houston. While platforms like Crunchbase and Pitch Book exist — and the HTX TechList will factor in their data — they can have costly memberships and be far from complete, since they only represent venture capital-backed startups.

"For the first time ever, you're pulling up a startup page and you're seeing all their fundraising history, the SDOs they're a part of, a blurb of what they're working on, and, the thing I'm most excited about is, their tags," Lalany says, adding that there's over 2,000 tags. "It makes the whole thing super searchable."

Lalany emphasizes that accuracy is HX's goal, and the organization has a data team to help to ensure validity. After launch, the emphasis will be on calling Houston innovators to create accounts for themselves and their companies. HX's next hire will likely be for a marketing person, Lalany mentions.

The technology has been white labeled from Israel's Startup Nation Central, which launched Israel Startup Finder in 2017.

"Israel, a couple years ago, was also an emerging ecosystem," says Lalany, explaining that the country wanted to work toward global attention. Meanwhile, she continues, "Houston has access to global markets, but there's been an misconception that innovation wasn't happening here."

The HX team has been working with Startup Nation Central for a while and been training on the platform since January, which has included a buildout of 300 profiles for the site. The TechList will launch on August 13 with a free virtual event featuring Mayor Sylvester Turner, Israel's Startup Finder team, and several. Houston innovators. (Note: InnovationMap is a media partner for the event.)

"When we were thinking about the launch event and just the sheer number of virtual events that happen now, we wanted to be sure that whatever we produce is of absolute value to our audience — the founders," Lalany says.

The event, which has registration open online, will feature breakout rooms focused on topics that are important to Houston founders:

  • Early stage investment
  • Building your team
  • How to pitch to the press
  • Landing an enterprise customer
  • Opportunity in Houston
  • Resources for founders of color

While the idea for the platform has been considered for years at HX — even in its early days, the need for the HTX TechList has been enhanced in light of the COVID-19 pandemic, Lalany says.

"The world changed in March, and our mission has become realized even more profoundly than before. Our mission has always been to help connect the dots in Houston — it's such a large city, and outsiders are always overwhelmed," she says. "Once we went digital, we were able to do 10 times as much of the curation function that we did pre-pandemic. It's increased a lot of our efficiency."

One-stop shop

Screenshot courtesy of HX

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”